[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-zealand-pharma-drops-31-after-disappointing-weight-loss-drug-trial-results-FR":150},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[],{"post":151,"seo":187,"relatedPosts":193,"suggestedPosts":273},{"id":152,"title":153,"date":154,"modified":155,"excerpt":156,"content":157,"wordCount":158,"lang":159,"uri":160,"slug":161,"cloudinaryAssetId":162,"featuredImageOriginalUrl":163,"featuredImageMetadata":164,"author":167,"editor":173,"categories":178,"relatedPosts":184,"seo":185},96095,"Zealand Pharma chute de 31 % après les résultats décevants d'un essai de médicament pour la perte de poids","2026-03-09T04:45:00","2026-03-09T04:24:21","\u003Cp>L'action de Zealand Pharma s'effondre de 35 % après que le petrelintide, un médicament amaigrissant, a donné des résultats inférieurs aux prévisions lors d'essais cliniques de phase intermédiaire.\u003C\u002Fp>\n","\n\u003Ch2 class=\"wp-block-heading\" id=\"h-k-ey-stats-for-zealand-pharma-stock\">\u003Cstrong>Statistiques clés\u003C\u002Fstrong> pour l'\u003Cstrong>action\u003C\u002Fstrong> Zealand Pharma\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Evolution du cours de l'action Zealand Pharma le vendredi 06 mars :\u003C\u002Fstrong> -31%.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Cours de l'action $ZLDPF au 6 mars :\u003C\u002Fstrong> 36\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Plus haut sur 52 semaines :\u003C\u002Fstrong> 106\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Objectif de cours de l'action $ZLDPF : \u003C\u002Fstrong> 99\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">En direct : Découvrez le potentiel de hausse de vos actions préférées en utilisant le nouveau modèle d'évaluation de TIKR (c'est gratuit).\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">&gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-happened\">Qu'est-ce qui s'est passé ?\u003C\u002Fh2>\n\n\n\n\u003Cp>L'action de\u003Cstrong>Zealand Pharma\u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=1268514&amp;tid=24964742&amp;ref=tikrblog\">(ZLDPF\u003C\u002Fa>) est en passe de connaître sa pire journée, chutant de plus de 31% après que \u003Ca href=\"https:\u002F\u002Fwww.cnbc.com\u002F2026\u002F03\u002F06\u002Fzealand-stock-zela-roche-trial-weight-loss-ceo-novo-glp1.html\">les résultats de l'essai\u003C\u002Fa> à mi-parcours de \u003Ca href=\"https:\u002F\u002Fwww.cnbc.com\u002F2026\u002F03\u002F06\u002Fzealand-stock-zela-roche-trial-weight-loss-ceo-novo-glp1.html\">son médicament pour la perte de poids, le petrelintide, aient déçu les investisseurs\u003C\u002Fa>.\u003C\u002Fp>\n\n\n\n\u003Cp>L'essai a montré que les patients ont perdu en moyenne 10,7 % de leur poids corporel en 42 semaines. \u003C\u002Fp>\n\n\n\n\u003Cp>Les analystes s'attendaient à une perte de poids comprise entre 13 et 20 %. Cet écart a suffi à faire chuter les actions de Zealand Pharma. Les actions de son partenaire Roche ont également chuté de 3 %.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"2560\" height=\"1707\" data-public-id=\"images\u002FTIKR.com_ZEAL-Zealand-Pharma-A_S-Revenue-and-Free-Cash-Flow\u002FTIKR.com_ZEAL-Zealand-Pharma-A_S-Revenue-and-Free-Cash-Flow.webp\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2560,h_1707,c_scale\u002Ff_webp,q_auto\u002Fv1772895121\u002Fimages\u002FTIKR.com_ZEAL-Zealand-Pharma-A_S-Revenue-and-Free-Cash-Flow\u002FTIKR.com_ZEAL-Zealand-Pharma-A_S-Revenue-and-Free-Cash-Flow.webp?_i=AA\" alt=\"\" class=\"wp-post-96095 wp-image-96178\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772895121\" data-seo=\"1\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Estimations du chiffre d'affaires et du flux de trésorerie disponible de l'action ZLFPF en milliards USD\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">(TIKR\u003C\u002Fa>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Le PDG Adam Steensberg a rapidement réagi. \u003C\u002Fp>\n\n\n\n\u003Cp>S'adressant à CNBC, il a affirmé que l'essai n'avait pas été conçu pour maximiser la perte de poids. Il s'agissait d'un essai avec une répartition hommes\u002Ffemmes de près de 50\u002F50, et les femmes perdent généralement plus de poids que les hommes avec ces médicaments. \u003C\u002Fp>\n\n\n\n\u003Cp>La plupart des concurrents prévoient 70 % de femmes dans leurs essais. Il s'est également dit \"confiant\" dans le fait que, dans des conditions optimisées, le pétrelintide pourrait entraîner une perte de poids de l'ordre d'une dizaine de kilos.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Voir les prévisions de croissance et les objectifs de prix des analystes pour l'action Zealand Pharma (C'est gratuit !) &gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-the-market-is-telling-us-about-zealand-pharma-stock\">Ce que le marché nous dit à propos de l'action Zealand Pharma\u003C\u002Fh2>\n\n\n\n\u003Cp>L'action Zealand Pharma a chuté parce que les chiffres de la perte de poids déterminent toujours le sentiment des investisseurs dans cet espace - même si le PDG n'est pas d'accord avec ce cadrage.\u003C\u002Fp>\n\n\n\n\u003Cp>M. Steensberg critique depuis longtemps ce qu'il appelle les \"Jeux olympiques de la perte de poids\", où les entreprises et les marchés sont obsédés par le nombre de kilos perdus par les patients plutôt que par la capacité de ces derniers à rester sous traitement. \u003C\u002Fp>\n\n\n\n\u003Cp>Son point de vue n'est pas faux. \u003C\u002Fp>\n\n\n\n\u003Cp>Environ la moitié des patients prenant des médicaments GLP-1 tels que Wegovy arrêtent de les prendre au bout d'un an, principalement en raison des effets secondaires et des coûts élevés. \u003C\u002Fp>\n\n\n\n\u003Cp>Une étude du BMJ a montré que les patients qui arrêtaient les médicaments GLP-1 revenaient à leur poids initial dans les deux ans.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"832\" height=\"505\" data-public-id=\"images\u002FZEAL-street-estimate_961799b5ee\u002FZEAL-street-estimate_961799b5ee.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_832,h_505,c_scale\u002Ff_webp,q_auto\u002Fv1772895174\u002Fimages\u002FZEAL-street-estimate_961799b5ee\u002FZEAL-street-estimate_961799b5ee.webp?_i=AA\" alt=\"\" class=\"wp-post-96095 wp-image-96179\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772895174\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1772895174\u002Fimages\u002FZEAL-street-estimate_961799b5ee\u002FZEAL-street-estimate_961799b5ee.webp?_i=AA 832w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_182,c_scale\u002Ff_webp,q_auto\u002Fv1772895174\u002Fimages\u002FZEAL-street-estimate_961799b5ee\u002FZEAL-street-estimate_961799b5ee.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_466,c_scale\u002Ff_webp,q_auto\u002Fv1772895174\u002Fimages\u002FZEAL-street-estimate_961799b5ee\u002FZEAL-street-estimate_961799b5ee.webp?_i=AA 768w\" sizes=\"auto, (max-width: 832px) 100vw, 832px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">ZLDPF Estimation de la rue\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">(TIKR\u003C\u002Fa>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Le Petrelintide agit différemment. Il cible l'amyline, une hormone qui affecte l'appétit et ralentit la digestion, plutôt que les récepteurs GLP-1 ou GIP ciblés par le Wegovy de Novo Nordisk et le Zepbound d'Eli Lilly. \u003C\u002Fp>\n\n\n\n\u003Cp>Lors de l'essai de jeudi, il n'y a eu aucun cas de vomissement et aucun patient n'a abandonné le traitement en raison d'effets secondaires gastro-intestinaux. Ce profil de tolérance est vraiment remarquable.\u003C\u002Fp>\n\n\n\n\u003Cp>Les analystes de Jefferies ont déclaré que le pétrelintide présentait une \"efficacité comparable à celle du Wegovy\" avec une tolérance proche du placebo, le qualifiant de \"médicament viable\". \u003C\u002Fp>\n\n\n\n\u003Cp>Mais ils ont également noté qu'il serait probablement considéré comme un second choix par rapport au médicament à base d'amyline que Lilly est en train de développer. \u003C\u002Fp>\n\n\n\n\u003Cp>Barclays a ajouté qu'il était peu probable que le marché accorde du crédit à Zealand pour une amélioration de la phase 3 dans deux ans.\u003C\u002Fp>\n\n\n\n\u003Cp>L'action de Zealand Pharma se situe actuellement à son niveau le plus bas depuis août 2023. \u003C\u002Fp>\n\n\n\n\u003Cp>La société prévoit de lancer un essai de phase 3 dans le courant de l'année. \u003C\u002Fp>\n\n\n\n\u003Cp>Le retour des investisseurs dépendra du caractère convaincant de l'amélioration des données - et si l'histoire de la tolérance finit par l'emporter sur les chiffres bruts de la perte de poids.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Estimez instantanément la juste valeur d'une société (gratuit avec TIKR) &gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-how-much-upside-does-zealand-pharma-stock-have-from-here\">Quelle est l'ampleur de la hausse de l'action Zealand Pharma à partir de maintenant ?\u003C\u002Fh2>\n\n\n\n\u003Cp>Avec le \u003Cstrong>nouveau modèle d'évaluation de\u003C\u002Fstrong> TIKR, vous pouvez estimer le prix potentiel d'une action en moins d'une minute.\u003C\u002Fp>\n\n\n\n\u003Cp>Il vous suffit d'entrer trois données simples :\u003C\u002Fp>\n\n\n\n\u003Col class=\"wp-block-list\">\n\u003Cli>\u003Cem>Croissance du chiffre d'affaires\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Marges d'exploitation\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Multiplicateur de prix de sortie\u003C\u002Fem>\u003C\u002Fli>\n\u003C\u002Fol>\n\n\n\n\u003Cp>Si vous n'êtes pas sûr de ce qu'il faut saisir, TIKR remplit automatiquement chaque entrée en utilisant les estimations consensuelles des analystes, ce qui vous donne un point de départ rapide et fiable.\u003C\u002Fp>\n\n\n\n\u003Cp>TIKR calcule ensuite le prix potentiel de l'action et le rendement total dans le cadre de \u003Cstrong>scénarios\u003C\u002Fstrong> \u003Cstrong>haussier, baissier et de base,\u003C\u002Fstrong> ce qui vous permet de voir rapidement si une action est \u003Cstrong>sous-évaluée ou surévaluée\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Découvrez la valeur réelle d'une action en moins de 60 secondes (gratuit avec TIKR) &gt;&gt;&gt;\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-looking-for-new-opportunities\">À la recherche de nouvelles opportunités ?\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Voyez quelles actions \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">les investisseurs milliardaires achètent\u003C\u002Fa> \u003C\u002Fstrong>afin que vous puissiez suivre l'argent intelligent.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Analysez les actions en seulement 5 minutes\u003C\u002Fa>\u003C\u002Fstrong> grâce à la plateforme tout-en-un et facile à utiliser de TIKR.\u003C\u002Fli>\n\n\n\n\u003Cli>Plus vous renversez de pierres... plus vous découvrirez d'opportunités. \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Recherchez plus de 100 000 actions mondiales, les titres des principaux investisseurs mondiaux, et plus encore avec TIKR.\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Avis de non-responsabilité :\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>\u003Cem>Veuillez noter que les articles de TIKR ne sont pas destinés à servir de conseils financiers ou d'investissement de la part de TIKR ou de notre équipe de contenu, et qu'ils ne constituent pas non plus des recommandations d'achat ou de vente d'actions. Nous créons notre contenu en nous basant sur les données d'investissement de TIKR Terminal et sur les estimations des analystes. Notre analyse peut ne pas inclure des nouvelles récentes de l'entreprise ou des mises à jour importantes. TIKR n'a aucune position dans les actions mentionnées. Nous vous remercions de votre lecture et vous souhaitons de bons investissements !\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp>\u003C\u002Fp>\n",740,"fr","\u002Fblog\u002Fzealand-pharma-drops-31-after-disappointing-weight-loss-drug-trial-results","zealand-pharma-drops-31-after-disappointing-weight-loss-drug-trial-results","images\u002FZLDPF-stock\u002FZLDPF-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772894500\u002Fimages\u002FZLDPF-stock\u002FZLDPF-stock.png?_i=AA",{"altText":165,"imageCredit":166},"Zealand Pharma Drops 31% After Disappointing Weight Loss Drug Trial Results","@Aflo Images from アフロ（Aflo）via Canva",{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":172},"Aditya Raghunath","adityatikr","author","",[],{"name":174,"slug":175,"role":176,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":177},"Thomas Richmond","thomastikr","editor",[],[179],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},"Investissement Général","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",0,[],{"title":165,"metaDesc":186,"opengraphDescription":186,"twitterTitle":165,"twitterDescription":186},"Zealand Pharma stock crashes 35% after weight-loss drug petrelintide showed lower-than-expected results in mid-stage clinical trials.",{"title":165,"description":186,"twitterTitle":165,"twitterDescription":186,"author":168,"articlePublisher":188,"articlePublishedTime":154,"articleModifiedTime":155,"twitterLabel1":189,"twitterData1":190,"ogTitle":165,"ogDescription":186,"ogUrl":160,"ogImage":163,"ogImageWidth":191,"ogImageHeight":192,"ogImageSecureUrl":163,"ogImageAlt":165,"twitterImage":163},"TIKR.com","Temps de lecture estimé","6 minutes",1200,630,[194,211,226,243,258],{"id":183,"title":195,"date":196,"excerpt":197,"wordCount":198,"uri":199,"slug":200,"cloudinaryAssetId":201,"featuredImageOriginalUrl":202,"featuredImageMetadata":203,"author":204,"categories":208,"relatedPosts":210},"L'action Spotify a baissé de 28% cette année, mais les analystes voient une hausse de 77% à venir","2026-03-08 15:20:00","Le résultat d'exploitation de Spotify est passé d'une perte de 446 millions d'euros en 2023 à 2,2 milliards d'euros en 2025, et les analystes estiment maintenant que les marges EBITDA atteindront 16 % d'ici 2026 et que la piste de la rentabilité se poursuivra.",815,"\u002Fblog\u002Fspotify-stock-is-down-28-this-year-but-analysts-see-77-upside-ahead","spotify-stock-is-down-28-this-year-but-analysts-see-77-upside-ahead","images\u002FFEATURED-IMAGE-MAKER-433\u002FFEATURED-IMAGE-MAKER-433","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1772979242\u002Fimages\u002FFEATURED-IMAGE-MAKER-433\u002FFEATURED-IMAGE-MAKER-433.png?_i=AA",{"altText":195},{"name":205,"slug":206,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":207},"Gian Estrada","giantikr",[],[209],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":212,"date":213,"excerpt":214,"wordCount":215,"uri":216,"slug":217,"cloudinaryAssetId":218,"featuredImageOriginalUrl":219,"featuredImageMetadata":220,"author":221,"categories":223,"relatedPosts":225},"Lululemon a chuté de 19 % en 2026 : les analystes voient-ils une reprise ?","2026-03-07 15:30:00","Le bénéfice par action de Lululemon devrait chuter de 10,9 % cette année, soit la première baisse consécutive depuis l'entrée en bourse de la société. Pourtant, l'action se négocie 51 % en dessous de son plus haut niveau sur 52 semaines, avec une capacité de rachat de 1,6 milliard de dollars qui n'est pas utilisée.",937,"\u002Fblog\u002Flululemon-fell-19-in-2026-do-analysts-see-recovery","lululemon-fell-19-in-2026-do-analysts-see-recovery","images\u002FFEATURED-IMAGE-MAKER-429\u002FFEATURED-IMAGE-MAKER-429","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1772893703\u002Fimages\u002FFEATURED-IMAGE-MAKER-429\u002FFEATURED-IMAGE-MAKER-429.png?_i=AA",{"altText":212},{"name":205,"slug":206,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":222},[],[224],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":227,"date":228,"excerpt":229,"wordCount":230,"uri":231,"slug":232,"cloudinaryAssetId":233,"featuredImageOriginalUrl":234,"featuredImageMetadata":235,"author":236,"categories":240,"relatedPosts":242},"Helios Technologies termine l'année de redressement avec un solide quatrième trimestre : Pourquoi un objectif de 76 $ est le prochain","2026-03-07 15:10:00","Helios Technologies, Inc. (HLIO) a clôturé un exercice 2025 transformateur par de solides résultats au quatrième trimestre, dépassant les attentes des analystes tant au niveau du chiffre d'affaires que du résultat net. ",964,"\u002Fblog\u002Fhelios-technologies-caps-turnaround-year-with-strong-q4-why-a-76-target-is-next","helios-technologies-caps-turnaround-year-with-strong-q4-why-a-76-target-is-next","images\u002F21_961213eeae\u002F21_961213eeae","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772865559\u002Fimages\u002F21_961213eeae\u002F21_961213eeae.png?_i=AA",{"altText":227},{"name":237,"slug":238,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":239},"Wiltone Asuncion","wiltonetikr",[],[241],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":244,"date":245,"excerpt":246,"wordCount":247,"uri":248,"slug":249,"cloudinaryAssetId":250,"featuredImageOriginalUrl":251,"featuredImageMetadata":252,"author":253,"categories":255,"relatedPosts":257},"Alamo Group chute de 15 % après avoir raté son quatrième trimestre : les analystes prévoient-ils une reprise en 2026 ?","2026-03-07 15:00:00","Alamo Group Inc. (ALG) a été confronté à de forts vents contraires au cours de son quatrième trimestre 2025, ce qui a déclenché une forte vente d'actions. ",934,"\u002Fblog\u002Falamo-group-drops-15-on-q4-miss-do-analysts-see-a-recovery-in-2026","alamo-group-drops-15-on-q4-miss-do-analysts-see-a-recovery-in-2026","images\u002F20_961204ee73\u002F20_961204ee73","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772865562\u002Fimages\u002F20_961204ee73\u002F20_961204ee73.png?_i=AA",{"altText":244},{"name":237,"slug":238,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":254},[],[256],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":259,"date":260,"excerpt":261,"wordCount":262,"uri":263,"slug":264,"cloudinaryAssetId":265,"featuredImageOriginalUrl":266,"featuredImageMetadata":267,"author":268,"categories":270,"relatedPosts":272},"Box fait un bond de 10 % grâce à la dynamique de l'IA : Voici où l'action pourrait se diriger en 2026","2026-03-07 14:50:00","Box, Inc. (BOX) a réalisé un excellent quatrième trimestre, annonçant un chiffre d'affaires annuel de 1,18 milliard de dollars et une forte adoption de sa plateforme Enterprise Advanced alimentée par l'IA.",1059,"\u002Fblog\u002Fbox-surges-10-on-ai-momentum-heres-where-the-stock-could-be-headed-in-2026","box-surges-10-on-ai-momentum-heres-where-the-stock-could-be-headed-in-2026","images\u002F19_96118bc62f\u002F19_96118bc62f","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772865568\u002Fimages\u002F19_96118bc62f\u002F19_96118bc62f.png?_i=AA",{"altText":259},{"name":237,"slug":238,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":269},[],[271],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],[274,292,306,321,336,356,371,386,401,416,434,449,463,477],{"id":183,"title":275,"date":276,"excerpt":277,"wordCount":278,"uri":279,"slug":280,"cloudinaryAssetId":281,"featuredImageOriginalUrl":282,"featuredImageMetadata":283,"author":284,"categories":286,"relatedPosts":291},"En hausse de 25 % au cours des trois dernières années, l'action Autodesk peut-elle offrir de meilleurs rendements jusqu'en 2029 ?","2026-03-09 04:45:00","Autodesk a dépassé ses prévisions pour l'exercice 26 sur tous les fronts. Mais sa marge de manœuvre en matière d'IA et l'expansion de ses marges peuvent-elles générer des rendements de plus de 30 % d'ici 2029 ? Voici ce que disent les chiffres.",1022,"\u002Fblog\u002Fup-25-in-last-3-years-can-autodesk-nasdaq-adsk-stock-deliver-better-returns-through-2029","up-25-in-last-3-years-can-autodesk-nasdaq-adsk-stock-deliver-better-returns-through-2029","images\u002FADSK-stock_9622108958\u002FADSK-stock_9622108958","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772946697\u002Fimages\u002FADSK-stock_9622108958\u002FADSK-stock_9622108958.png?_i=AA",{"altText":275},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":285},[],[287],{"name":288,"slug":289,"uri":290,"description":171,"postsCount":183},"Évaluation","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":183,"title":293,"date":276,"excerpt":294,"wordCount":295,"uri":296,"slug":297,"cloudinaryAssetId":298,"featuredImageOriginalUrl":299,"featuredImageMetadata":300,"author":301,"categories":303,"relatedPosts":305},"En hausse de 79% en 3 ans, l'action Republic Services peut-elle offrir de meilleurs rendements en 2026 ?","L'action Republic Services pourrait atteindre 282 dollars d'ici 2028 avec un rendement de 22%. Les marges solides et les investissements en IA compensent les vents contraires en termes de volume dans le secteur de la gestion des déchets.",1454,"\u002Fblog\u002Fup-79-in-3-years-can-republic-services-nyse-stock-deliver-better-returns-in-2026","up-79-in-3-years-can-republic-services-nyse-stock-deliver-better-returns-in-2026","images\u002FRSG-stock_962494a7e5\u002FRSG-stock_962494a7e5","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772968935\u002Fimages\u002FRSG-stock_962494a7e5\u002FRSG-stock_962494a7e5.png?_i=AA",{"altText":293},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":302},[],[304],{"name":288,"slug":289,"uri":290,"description":171,"postsCount":183},[],{"id":183,"title":307,"date":308,"excerpt":309,"wordCount":310,"uri":311,"slug":312,"cloudinaryAssetId":313,"featuredImageOriginalUrl":314,"featuredImageMetadata":315,"author":316,"categories":318,"relatedPosts":320},"En hausse de 177 % au cours des 12 derniers mois, l'action Celestica est-elle encore un bon achat ?","2026-03-05 12:58:00","Le boom de l'infrastructure d'IA de Celestica entraîne une croissance de 44 % au quatrième trimestre. L'action pourrait atteindre 431 $ d'ici la fin de 2028, offrant une hausse de 68 % à mesure que les hyperscalers augmentent leurs investissements dans les centres de données.",1172,"\u002Fblog\u002Fdraft-up-177-in-last-12-months-is-celestica-nyse-stock-still-a-good-buy-right-now","draft-up-177-in-last-12-months-is-celestica-nyse-stock-still-a-good-buy-right-now","images\u002FCLS-stock\u002FCLS-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772607463\u002Fimages\u002FCLS-stock\u002FCLS-stock.png?_i=AA",{"altText":307},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":317},[],[319],{"name":288,"slug":289,"uri":290,"description":171,"postsCount":183},[],{"id":183,"title":322,"date":323,"excerpt":324,"wordCount":325,"uri":326,"slug":327,"cloudinaryAssetId":328,"featuredImageOriginalUrl":329,"featuredImageMetadata":330,"author":331,"categories":333,"relatedPosts":335},"En baisse de 11 % par rapport à son plus haut niveau historique, l'action Colgate peut-elle offrir de nouveaux rendements en 2026 ?","2026-03-05 04:45:00","Colgate-Palmolive vise un rendement de 19 % jusqu'en 2028 grâce à une stratégie de premiumisation et à la croissance des marchés émergents, malgré les vents contraires en Amérique du Nord et la faiblesse des catégories.",1222,"\u002Fblog\u002Fdraft-down-11-from-all-time-high-can-colgate-nyse-stock-deliver-further-returns-in-2026","draft-down-11-from-all-time-high-can-colgate-nyse-stock-deliver-further-returns-in-2026","images\u002FCL-stock\u002FCL-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772596480\u002Fimages\u002FCL-stock\u002FCL-stock.png?_i=AA",{"altText":322},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":332},[],[334],{"name":288,"slug":289,"uri":290,"description":171,"postsCount":183},[],{"id":183,"title":337,"date":338,"excerpt":339,"wordCount":340,"uri":341,"slug":342,"cloudinaryAssetId":343,"featuredImageOriginalUrl":344,"featuredImageMetadata":345,"author":346,"categories":350,"relatedPosts":355},"L'action de Trade Desk bondit de 18% après le rapport sur les pourparlers publicitaires d'OpenAI. Les analystes voient un objectif de 32 $.","2026-03-06 18:15:00","Voici pourquoi l'action de Trade Desk a bondi de 18 % après la publication d'informations selon lesquelles OpenAI a entamé des discussions avec l'entreprise pour vendre des publicités.",872,"\u002Fblog\u002Ftrade-desk-stock-jumps-18-after-openai-ad-talks-report-analysts-see-32-target","trade-desk-stock-jumps-18-after-openai-ad-talks-report-analysts-see-32-target","images\u002FTTD-stock-1\u002FTTD-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772818203\u002Fimages\u002FTTD-stock-1\u002FTTD-stock-1.png?_i=AA",{"altText":337},{"name":347,"slug":348,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":349},"Rexielyn Diaz","rexietikr",[],[351],{"name":352,"slug":353,"uri":354,"description":171,"postsCount":183},"Examens des Actions","reviews","\u002Fblog\u002Fcategory\u002Freviews",[],{"id":183,"title":357,"date":358,"excerpt":359,"wordCount":360,"uri":361,"slug":362,"cloudinaryAssetId":363,"featuredImageOriginalUrl":364,"featuredImageMetadata":365,"author":366,"categories":368,"relatedPosts":370},"Voici pourquoi l'action Arm pourrait rapporter 187 % après avoir baissé de 3 % l'an dernier","2026-03-06 15:30:00","Arm vient d'enregistrer le meilleur trimestre de son histoire, mais la société a un événement à organiser le 24 mars qu'elle refuse de dévoiler, et l'histoire de la réaccélération des redevances CSS n'a peut-être pas encore atteint son apogée.",928,"\u002Fblog\u002Fheres-why-arm-stock-could-return-187-after-declining-3-last-year","heres-why-arm-stock-could-return-187-after-declining-3-last-year","images\u002FFEATURED-IMAGE-MAKER-422\u002FFEATURED-IMAGE-MAKER-422","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1772810030\u002Fimages\u002FFEATURED-IMAGE-MAKER-422\u002FFEATURED-IMAGE-MAKER-422.png?_i=AA",{"altText":357},{"name":205,"slug":206,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":367},[],[369],{"name":352,"slug":353,"uri":354,"description":171,"postsCount":183},[],{"id":183,"title":372,"date":373,"excerpt":374,"wordCount":375,"uri":376,"slug":377,"cloudinaryAssetId":378,"featuredImageOriginalUrl":379,"featuredImageMetadata":380,"author":381,"categories":383,"relatedPosts":385},"L'action de Tango Therapeutics bondit de 36 % pour atteindre un nouveau sommet. Voici les raisons de ce mouvement","2026-03-06 14:40:00","Voici pourquoi l'action de Tango Therapeutics a bondi de 36% après un nouveau partenariat pour un médicament contre le cancer et de nouveaux jalons pour le pipeline 2026.",886,"\u002Fblog\u002Ftango-therapeutics-stock-jumps-36-to-a-new-high-heres-whats-driving-the-move","tango-therapeutics-stock-jumps-36-to-a-new-high-heres-whats-driving-the-move","images\u002FTNGX-stock\u002FTNGX-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772805881\u002Fimages\u002FTNGX-stock\u002FTNGX-stock.png?_i=AA",{"altText":372},{"name":347,"slug":348,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":382},[],[384],{"name":352,"slug":353,"uri":354,"description":171,"postsCount":183},[],{"id":183,"title":387,"date":388,"excerpt":389,"wordCount":390,"uri":391,"slug":392,"cloudinaryAssetId":393,"featuredImageOriginalUrl":394,"featuredImageMetadata":395,"author":396,"categories":398,"relatedPosts":400},"L'action de Sable Offshore bondit de 37 % après le développement du pipeline. Les analystes voient un objectif de 25","2026-03-06 14:00:00","Voici pourquoi l'action de Sable Offshore a bondi de 37 %, les investisseurs se concentrant sur les progrès du redémarrage des pipelines et sur le potentiel de production pétrolière à venir.",859,"\u002Fblog\u002Fsable-offshore-stock-surges-37-after-pipeline-developments-analysts-see-25-target","sable-offshore-stock-surges-37-after-pipeline-developments-analysts-see-25-target","images\u002FSOC-stock\u002FSOC-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772805070\u002Fimages\u002FSOC-stock\u002FSOC-stock.png?_i=AA",{"altText":387},{"name":347,"slug":348,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":397},[],[399],{"name":352,"slug":353,"uri":354,"description":171,"postsCount":183},[],{"id":183,"title":402,"date":403,"excerpt":404,"wordCount":405,"uri":406,"slug":407,"cloudinaryAssetId":408,"featuredImageOriginalUrl":409,"featuredImageMetadata":410,"author":411,"categories":413,"relatedPosts":415},"L'action Chevron est en hausse de 22 % en 2026 et les analystes prévoient une hausse de 55 % à partir de maintenant","2026-03-06 12:30:00","La marge de flux de trésorerie disponible de Chevron a atteint 7,4 % en 2024 et devrait atteindre 16,2 % d'ici 2029, soit près du double du plafond projeté par Exxon, tandis que l'objectif intermédiaire de 295,41 $ de TIKR se situe à 55 % au-dessus du prix d'aujourd'hui.",1068,"\u002Fblog\u002Fchevron-stock-is-up-22-in-2026-and-analysts-see-another-55-upside-from-here","chevron-stock-is-up-22-in-2026-and-analysts-see-another-55-upside-from-here","images\u002FFEATURED-IMAGE-MAKER-419\u002FFEATURED-IMAGE-MAKER-419","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1772773947\u002Fimages\u002FFEATURED-IMAGE-MAKER-419\u002FFEATURED-IMAGE-MAKER-419.png?_i=AA",{"altText":402},{"name":205,"slug":206,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":412},[],[414],{"name":352,"slug":353,"uri":354,"description":171,"postsCount":183},[],{"id":183,"title":417,"date":418,"excerpt":419,"wordCount":420,"uri":421,"slug":422,"cloudinaryAssetId":423,"featuredImageOriginalUrl":424,"featuredImageMetadata":425,"author":426,"categories":428,"relatedPosts":433},"L'action de Ross Stores fait un bond de 4 % alors que le détaillant dépasse ses estimations trimestrielles avec une croissance des ventes à deux chiffres","2026-03-06 11:50:00","L'action Block a augmenté de plus de 20 % après que la société fintech a annoncé qu'elle allait licencier plus de 4 000 employés, soit environ la moitié de ses effectifs.",701,"\u002Fblog\u002Fross-stores-nasdaq-stock-pop-as-retailer-beats-quarterly-estimates-with-double-digit-sales-growth","ross-stores-nasdaq-stock-pop-as-retailer-beats-quarterly-estimates-with-double-digit-sales-growth","images\u002FROST-stock_9595668f1f\u002FROST-stock_9595668f1f","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772726947\u002Fimages\u002FROST-stock_9595668f1f\u002FROST-stock_9595668f1f.png?_i=AA",{"altText":417},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":427},[],[429],{"name":430,"slug":431,"uri":432,"description":171,"postsCount":183},"Mises à Jour des Résultats","earnings-updates","\u002Fblog\u002Fcategory\u002Fearnings-updates",[],{"id":183,"title":435,"date":436,"excerpt":437,"wordCount":438,"uri":439,"slug":440,"cloudinaryAssetId":441,"featuredImageOriginalUrl":442,"featuredImageMetadata":443,"author":444,"categories":446,"relatedPosts":448},"L'action Gap chute de 6 % après que les résultats du quatrième trimestre ont été inférieurs aux attentes des analystes","2026-03-06 11:40:00","L'action Gap a chuté de 9 % après que les bénéfices du quatrième trimestre ont manqué les estimations, plombés par les perturbations dues à la tempête hivernale, les vents contraires tarifaires et des prévisions qui n'ont pas impressionné.",697,"\u002Fblog\u002Fgap-nyse-stock-slides-after-fourth-quarter-earnings-miss-analyst-expectations","gap-nyse-stock-slides-after-fourth-quarter-earnings-miss-analyst-expectations","images\u002FGAP-stock_9599154bdc\u002FGAP-stock_9599154bdc","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772780889\u002Fimages\u002FGAP-stock_9599154bdc\u002FGAP-stock_9599154bdc.png?_i=AA",{"altText":435},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":445},[],[447],{"name":430,"slug":431,"uri":432,"description":171,"postsCount":183},[],{"id":183,"title":450,"date":436,"excerpt":451,"wordCount":452,"uri":453,"slug":454,"cloudinaryAssetId":455,"featuredImageOriginalUrl":456,"featuredImageMetadata":457,"author":458,"categories":460,"relatedPosts":462},"L'action de Marvell Technology bondit de 13 %, la demande en matière d'IA étant à l'origine d'un résultat trimestriel positif","Marvell Technology a battu les estimations du quatrième trimestre avec un chiffre d'affaires record, a revu à la hausse ses perspectives pour l'exercice 2027 et estime que la demande d'infrastructures d'IA sera le moteur de la croissance jusqu'en 2028.",662,"\u002Fblog\u002Fmarvell-technology-nasdaq-mrvl-stock-surges-15-as-ai-demand-drives-quarterly-beat","marvell-technology-nasdaq-mrvl-stock-surges-15-as-ai-demand-drives-quarterly-beat","images\u002FMRVL-stock_95987bedd7\u002FMRVL-stock_95987bedd7","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772777936\u002Fimages\u002FMRVL-stock_95987bedd7\u002FMRVL-stock_95987bedd7.png?_i=AA",{"altText":450},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":459},[],[461],{"name":430,"slug":431,"uri":432,"description":171,"postsCount":183},[],{"id":183,"title":464,"date":436,"excerpt":465,"wordCount":466,"uri":467,"slug":468,"cloudinaryAssetId":469,"featuredImageOriginalUrl":470,"featuredImageMetadata":471,"author":472,"categories":474,"relatedPosts":476},"Les actions de Costco chutent de 2 %, alors que les revenus tirés des frais d'adhésion augmentent de 13 %.","Costco a battu les estimations pour le deuxième trimestre avec une croissance des bénéfices de 14 % et une augmentation des cotisations de 13 %, tout en s'engageant à répercuter les remboursements tarifaires sur les membres par le biais d'une baisse des prix.",654,"\u002Fblog\u002Fcostco-stock-nasdaq-dip-2-despite-membership-fee-revenue-jump-of-13","costco-stock-nasdaq-dip-2-despite-membership-fee-revenue-jump-of-13","images\u002FCOSTCO-stock_95994a66b6\u002FCOSTCO-stock_95994a66b6","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772782394\u002Fimages\u002FCOSTCO-stock_95994a66b6\u002FCOSTCO-stock_95994a66b6.png?_i=AA",{"altText":464},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":473},[],[475],{"name":430,"slug":431,"uri":432,"description":171,"postsCount":183},[],{"id":183,"title":478,"date":479,"excerpt":480,"wordCount":481,"uri":482,"slug":483,"cloudinaryAssetId":484,"featuredImageOriginalUrl":485,"featuredImageMetadata":486,"author":487,"categories":489,"relatedPosts":491},"L'action de Burlington Stores bondit de 7 % après que le détaillant a dépassé ses objectifs trimestriels en matière de bénéfices et de chiffre d'affaires","2026-03-06 11:20:00","L'action Burlington Stores a bondi après que le bénéfice par action ajusté du quatrième trimestre ait augmenté de 21 % et que les comps aient dépassé les prévisions, la direction se montrant optimiste quant aux opportunités de vente pour 2026.",781,"\u002Fblog\u002Fburlington-stores-nyse-burl-stock-pops-after-retailer-beats-quarterly-profit-and-revenue-targets","burlington-stores-nyse-burl-stock-pops-after-retailer-beats-quarterly-profit-and-revenue-targets","images\u002FBURL-stock\u002FBURL-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772793880\u002Fimages\u002FBURL-stock\u002FBURL-stock.png?_i=AA",{"altText":478},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":488},[],[490],{"name":430,"slug":431,"uri":432,"description":171,"postsCount":183},[]]